Non-Alcoholic Steatohepatitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Non-Alcoholic Steatohepatitis (NASH) Clinical Trials Market Report Overview
The Non-Alcoholic Steatohepatitis (NASH) clinical trial market research report provides an overview of the NASH clinical trials scenario. The report provides top-line data relating to the clinical trials on NASH. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
NASH Clinical Trials Market Segmentation by Regions and Countries
The key regions in the NASH clinical trials market are Europe, North America, the Middle East & Africa, Asia-Pacific, and South & Central America, among others. As of March 2023, out of all the clinical trials conducted on NASH, the majority were conducted in North America.
As of March 2023, in the country-wise analysis, the US has the highest number of NASH clinical trials and Spain has the highest average patient enrollment. The other countries included are Japan, China, the UK, Australia, France, Canada, Germany, and Belgium.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, France has the highest proportion of NASH to gastrointestinal clinical trials as of March 2023.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Mexico has the highest proportion of NASH to gastrointestinal clinical trials as of March 2023.
NASH Clinical Trials Analysis by Regions, 2023 (%)
For more regional insights into the NASH clinical trials market, download a free report sample
NASH Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the NASH clinical trials market are institution, company, and the government. Out of them, the company sponsor type dominates the NASH clinical trials market.
NASH Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
For more sponsor type insights into the NASH clinical trials market, download a free report sample
NASH Clinical Trials Market - Competitive Landscape
The leading sponsors in the NASH clinical trials market are Pfizer Inc, ICON Plc, Gilead Sciences Inc, Novartis AG, Novo Holdings AS, and Thermo Fisher Scientific Inc among others. Pfizer Inc has conducted the highest number of NASH clinical trials as of March 2023, followed by ICON Plc and Gilead Sciences Inc.
NASH Clinical Trials Market Analysis by Sponsors, 2023 (%)
To know more about the leading sponsors in the NASH clinical trials market, download a free report sample
NASH Clinical Trials Market Report Overview
| Key Regions | Europe, North America, The Middle East & Africa, Asia-Pacific, and South & Central America |
| Key Countries | The US, China, Japan, the UK, Australia, France, Canada, Germany, and Belgium |
| Key Sponsor Types | Institution, Company, and Government |
| Leading Sponsors | Pfizer Inc, ICON Plc, Gilead Sciences Inc, Novartis AG, Novo Holdings AS, and Thermo Fisher Scientific Inc |
Segments Covered in the Report
NASH Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- North America
- Europe
- Middle East & Africa
- South & Central America
NASH Clinical Trials Country Outlook (2023)
- The US
- China
- Japan
- The UK
- Australia
- Canada
- France
- Germany
- Belgium
NASH Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end point status.
- The report reviews the top companies involved and enlists all trials (Trial title, Phase, and Status) about the company.
- The report provides all the unaccomplished trials (Terminated, Suspended, and Withdrawn) with the reason for unaccomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regard to investment.
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost.
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities.
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Facilitates clinical trial assessment of the indication on a global, regional, and country level.
Key Players
Table of Contents
List of Tables
List of Figures
Frequently Asked Questions
The key regions in the NASH clinical trials market are Europe, North America, the Middle East & Africa, Asia-Pacific, and South & Central America.
The key countries in the NASH clinical trials market are the US, China, Japan, the UK, Australia, France, Canada, Germany, and Belgium.
The key sponsor types in the NASH clinical trials market are institution, company, and the government.
Some of the leading sponsors in the NASH clinical trials market are Pfizer Inc, ICON Plc, Gilead Sciences Inc, Novartis AG, Novo Holdings AS, and Thermo Fisher Scientific Inc.
Get in touch to find out about our multi-purchase discounts
reportstore@globaldata.com
Tel +44 (0) 20 7947 2960
Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.
Testimonial
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Related reports
View more Non-Alcoholic Steatohepatitis (NASH) reports